Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial

Shokrpour, Maryam, Foroozanfard, Fatemeh, Afshar Ebrahimi, Faraneh, Vahedpoor, Zahra, Aghadavod, Esmat, Ghaderi, Amir, Asemi, Zatollah · 2019 · Gynecological Endocrinology

Abstract

This investigation was conducted to evaluate comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome (PCOS). This randomized controlled trial was conducted on 53 women with PCOS, aged 18-40 years old. Subjects were randomly allocated into two groups to take either myo-inositol (n = 26) or metformin (n = 27) for 12 weeks. Myo-inositol supplementation, compared with metformin, significantly reduced fasting plasma glucose (FPG) (β -5.12 mg/dL; 95% CI, -8.09, -2.16; p=.001), serum insulin levels (β -1.49 µIU/mL; 95% CI, -2.28, -0.70; p<.001), homeostasis model of assessment-insulin resistance (β -0.36; 95% CI, -0.55, -0.17; p<.001), serum triglycerides (β 12.42 mg/dL; 95% CI, -20.47, -4.37; p=.003) and VLDL-cholesterol levels (β -2.48 mg/dL; 95% CI, -4.09, -0.87; p=.003), and significantly increased the quantitative insulin sensitivity check index (β 0.006; 95% CI, 0.002, 0.01; p=.006) compared with metformin. Moreover, myo-inositol supplementation upregulated gene expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) (p=.002) compared with metformin. Overall, taking myo-inositol, compared with metformin, for 12 weeks by women with PCOS had beneficial effects on glycemic control, triglycerides and VLDL-cholesterol levels, and gene expression of PPAR-γ.

Overview

Integrity signals

Registry

Crossref · 10.1080/09513590.2018.1540570

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

The citation lists haven’t been fetched yet

References 41 · Cited by 63

Research works printed but not linked: 5

  1. Mansour A, 2016, EXCIL J, 15, 551
  2. Kapral M, 2013, Acta Pol Pharm, 2013, 1
  3. Gerli S, 2007, Eur Rev Med Pharmacol Sci, 11, 347
  4. Costantino D, 2009, Eur Rev Med Pharmacol Sci, 13, 105
  5. Rago R, 2015, J Biol Regul Homeost Agents, 29, 913

Metadata

Authors
Shokrpour, M., Foroozanfard, F., Afshar Ebrahimi, F., Vahedpoor, Z., Aghadavod, E., Ghaderi, A., & Asemi, Z.
Affiliations
  • Arak University of Medical Sciences (IR)
  • Kashan University of Medical Sciences (IR)
  • Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran;
Corresponding author
Asemi, Zatollah
Venue
Gynecological Endocrinology
Published
2019-01-04
Volume
35
Issue
5
Pages
406-411
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W2907087060
Cited by
63
References
41
Citations by year
2026: 3 · 2025: 8 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 5 · 2020: 9 · 2019: 3
FWCI
7.17
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
polycystic ovary syndrome, myo-inositol, metformin, glycemic control, insulin resistance, lipid profile, triglycerides, VLDL cholesterol, PPARγ, gene expression, insulin sensitivity, fasting blood glucose
MeSH terms
Adolescent, Adult, Blood Glucose, Female, Humans, Hypoglycemic Agents, Inositol, Insulin, Lipids, Metformin, Polycystic Ovary Syndrome, Gene Expression, Treatment Outcome, Lipid Metabolism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. https://app.cochat.ai/papers/10.1080/09513590.2018.1540570
The paper
Shokrpour, M., Foroozanfard, F., Afshar Ebrahimi, F., Vahedpoor, Z., Aghadavod, E., Ghaderi, A., & Asemi, Z. (2019). Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2018.1540570

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.